These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24361355)

  • 1. Methodological agreement on the in vitro activity of ceftaroline against cefotaxime-susceptible and -resistant pneumococci.
    Livermore DM; Warner M; Mushtaq S
    Int J Antimicrob Agents; 2014 Feb; 43(2):131-4. PubMed ID: 24361355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility testing challenges with ceftaroline, MRSA and a 1 mg/L breakpoint.
    Livermore DM; Mushtaq S; Warner M; James D; Woodford N
    J Antimicrob Chemother; 2015 Dec; 70(12):3259-66. PubMed ID: 26318188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of ceftaroline against serotyped Streptococcus pneumoniae isolates from Europe and South Africa associated with community-acquired bacterial pneumonia (2007-08).
    Morrissey I; Leakey A
    J Antimicrob Chemother; 2012 Jun; 67(6):1408-12. PubMed ID: 22357801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
    Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A; Major P
    Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness.
    Soriano F; Cafini F; Aguilar L; Tarragó D; Alou L; Giménez MJ; Gracia M; Ponte MC; Leu D; Pana M; Letowska I; Fenoll A
    J Antimicrob Chemother; 2008 Dec; 62(6):1234-40. PubMed ID: 18799472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.
    Zhanel GG; Yachison C; Nichol K; Adam H; Noreddin AM; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2012 Jul; 67(7):1706-11. PubMed ID: 22467630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of ceftaroline versus ceftobiprole against staphylococci and pneumococci in the UK and Ireland: analysis of BSAC surveillance data.
    Horner C; Mushtaq S; Livermore DM;
    J Antimicrob Chemother; 2020 Nov; 75(11):3239-3243. PubMed ID: 32728710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia.
    Morrissey I; Ge Y; Janes R
    Int J Antimicrob Agents; 2009 Jun; 33(6):515-9. PubMed ID: 19203863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of cefepime and cefotaxime compared to six other agents against 350 penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Gomez-Lus R; Navarro C; Egido P; Aspiroz C; Goñi P; Vergara Y; Garcia C; Duran E; Castillo J; Rubio MC
    J Chemother; 2000 Feb; 12(1):17-21. PubMed ID: 10768511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etest® versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre study.
    Cantón R; Livermore DM; Morosini MI; Díaz-Regañón J; Rossolini GM;
    J Antimicrob Chemother; 2017 Feb; 72(2):431-436. PubMed ID: 27798220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the results of the Etest and the method for determining minimum inhibitory concentrations in solid media for penicillin G, amoxicillin, and cefotaxime for S. pneumoniae. A multicenter study].
    Clavier B; Perrier-Gros-Claude JD; Foissaud V; Dumas M; Aubert G; Barbé G; Bland S; Boucaud Maitre Y; Boyer M; Chomarat M; Clergeau P; Delubac F; Févre D; Fuhrmann C; Gravagnat B; Letouzey MN; Mandjee A; Martelet P; Meley R; Reverdy ME; Ros A; Roure C; Sabot O; Tixier A; Thierry J
    Pathol Biol (Paris); 1998 Jun; 46(6):369-74. PubMed ID: 9769863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
    Pfaller MA; Farrell DJ; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agar.
    Johnson AP; Mushtaq S; Warner M; Livermore DM
    J Antimicrob Chemother; 2004 May; 53(5):860-2. PubMed ID: 15056637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of telavancin and comparators against selected groups of Gram-positive cocci.
    Hope R; Chaudhry A; Adkin R; Livermore DM
    Int J Antimicrob Agents; 2013 Mar; 41(3):213-7. PubMed ID: 23298432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
    Pankuch GA; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
    Jacobs MR; Good CE; Windau AR; Bajaksouzian S; Biek D; Critchley IA; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2716-9. PubMed ID: 20308374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic susceptibility of clinical isolates of Streptococcus pneumoniae.
    Traub WH; Leonhard B
    Chemotherapy; 1996; 42(4):240-7. PubMed ID: 8804790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.